Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a Phase 1 trial registration with no results posted; the study is active but not yet recruiting and designed to establish safety and tolerability before efficacy assessment.
Phase 2 dose-escalation trial with estimated enrollment of 300 participants; no results reported in this registry record, only design and planned outcomes.
This is a Phase 3 RCT registration with no results posted; the study is active but not yet recruiting and outcomes have not been reported, making it a planned trial rather than evidence of efficacy.
This is an ongoing Phase 2 trial registration with no results reported; it describes a planned study of tolerability in a molecularly defined but small population, which cannot yet inform clinical practice.
This is a Phase 1 bioequivalence study registration with no results posted; it describes a planned pharmacokinetic comparison in healthy volunteers and those with overweight/obesity.
Phase 1 trial with completed enrollment testing tolerability and efficacy of an investigational antidepressant; no results posted in registry, so evidence strength cannot be assessed.